147 related articles for article (PubMed ID: 8594994)
1. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.
Doll MA; Fretland AJ; Deitz AC; Hein DW
Anal Biochem; 1995 Nov; 231(2):413-20. PubMed ID: 8594994
[TBL] [Abstract][Full Text] [Related]
2. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
[TBL] [Abstract][Full Text] [Related]
3. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
5. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y
Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
7. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
[TBL] [Abstract][Full Text] [Related]
8. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles.
Deitz AC; Doll MA; Hein DW
Anal Biochem; 1997 Nov; 253(2):219-24. PubMed ID: 9367506
[TBL] [Abstract][Full Text] [Related]
9. Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
Bolt HM; Selinski S; Dannappel D; Blaszkewicz M; Golka K
Arch Toxicol; 2005 Apr; 79(4):196-200. PubMed ID: 15558239
[TBL] [Abstract][Full Text] [Related]
10. An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction.
Abe M; Suzuki T; Deguchi T
Jpn J Hum Genet; 1993 Jun; 38(2):163-8. PubMed ID: 8102908
[TBL] [Abstract][Full Text] [Related]
11. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
Prawan A; Kukongviriyapan V; Tassaneeyakul W; Pairojkul C; Bhudhisawasdi V
Eur J Cancer Prev; 2005 Jun; 14(3):245-50. PubMed ID: 15901993
[TBL] [Abstract][Full Text] [Related]
12. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
13. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
14. Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes.
Blömeke B; Sieben S; Spötter D; Landt O; Merk HF
Anal Biochem; 1999 Nov; 275(1):93-7. PubMed ID: 10542113
[TBL] [Abstract][Full Text] [Related]
15. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil.
Teixeira RL; Miranda AB; Pacheco AG; Lopes MQ; Fonseca-Costa J; Rabahi MF; Melo HM; Kritski AL; Mello FC; Suffys PN; Santos AR
Mutat Res; 2007 Nov; 624(1-2):31-40. PubMed ID: 17509624
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India.
Anitha A; Banerjee M
Int J Mol Med; 2003 Jan; 11(1):125-31. PubMed ID: 12469231
[TBL] [Abstract][Full Text] [Related]
18. N-acetyltransferase 2 gene polymorphism and presbycusis.
Unal M; Tamer L; Doğruer ZN; Yildirim H; Vayisoğlu Y; Camdeviren H
Laryngoscope; 2005 Dec; 115(12):2238-41. PubMed ID: 16369173
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of polymorphism in N-acetyltransferase 1 and 2 genes by reverse line blot hybridization.
Bunschoten A; Tiemersma E; Schouls L; Kampman E
Anal Biochem; 2000 Oct; 285(1):156-62. PubMed ID: 10998276
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.
Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M
Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
